Trump: 'I don’t agree' with Fauci over US testing capabilities to curb coronavirus [FOX News]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: FOX News
closeVideoFox News Flash top headlines for April 23Fox News Flash top headlines are here. Check out what's clicking on Foxnews.com.Get all the latest news on coronavirus and more delivered daily to your inbox.Sign up herePresident TrumpDr. Anthony FauciIn an interview with Time that was published Thursday, Fauci -- the top infectious disease expert and member of theWhite “We need to significantly ramp up not only the number of tests, but the capacity to perform them, so that you don’t have a situation where you have a test, but it can’t be done because there isn’t a swab, or because there isn’t extraction media or not the right vial,” Fauci told Time. “I am not overly confident right now at all that we have what it takes to do that. We are doing better, and I think we are going to get there, but we are not there yet.”Trump said Thursday he disagreed with Fauci's remarks, claiming the is "very advanced in testing."EX-WORLD BANK ECONOMIST PUSHES $100B PLAN TO TEST EVERYONE IN US EVERY
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Abbott Laboratories (NYSE: ABT) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $130.00 price target on the stock.MarketBeat
- Pregnancy Detection Kits Industry Report 2024, Featuring Key Players Alere, Church & Dwight, Confirm BioSciences, CVS Health, Mankind Pharma, Philippine Blue Cross Biotech, Prestige Brands and Quidel [Yahoo! Finance]Yahoo! Finance
- Guidewires Market to grow by USD 807 Million from 2024-2028, driven by rising chronic disorders, AI-powered report highlights impact on market trends - Technavio [Yahoo! Finance]Yahoo! Finance
- Global Drug Device Combination Products Market is expected to reach revenue of USD 389.7 Bn by 2033, at 9.3% CAGR: Dimension Market Research. [Yahoo! Finance]Yahoo! Finance
- Organic Baby Formula Market to Reach $17.7 Billion, Globally, by 2033 at 9.5% CAGR: Allied Market Research [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 7/18/24 - Beat
ABT
Sec Filings
- 10/1/24 - Form 4
- 10/1/24 - Form 4
- 10/1/24 - Form 4
- ABT's page on the SEC website